Beautiful Virgin Islands

Monday, Jun 30, 2025

‘Amazon of antibodies’ Abcam buys up US supplier in $340million deal

‘Amazon of antibodies’ Abcam buys up US supplier in $340million deal

Cambridge-based biotech Abcam is buying Californian diagnostics pioneer BioVision in a $340million cash deal to bring one of its long-term partners in-house.
Abcam was launched in 1988 by founder Jonathan Milner who cycled around local research companies with an ice-bucket containing antibodies to sell to local scientists working in nearby labs.

It now has more than 1,100 employees in 11 countries, with a market cap of around $3billion, and is known as the “Amazon of antibodies” supplying proteins, assay kits and reagents to two thirds of the world’s scientific researchers.

BioVision started supplying Abcam with its biochemical and cell-based assay kits in 2003, and sales of its products which are used in research, diagnostics, and drug discovery have more than doubled over the past five years.

The firm said the acquisition will give Abcam more control over the innovation and distribution of its target company’s product portfolio.
The bid is subject to

review and approval of the Shenzhen Stock Exchange and by a vote of Chinese parent company Boai NKY Medical Holdings’ shareholders. If approved, the deal is expected to close before the end of the 2021 calendar year.

For the 12 months ended 31 December 2020, BioVision reported revenues of $33.8 million (£24.3 million), operating profit of $12.6 million (£9.1 million) and net assets of $21.9 million (£15.7 million).

Revenues included approximately $5 million of COVID-19 related product sales which are not expected to repeat.

Abcam says the acquisition will be funded from existing cash resources and a partial drawdown of its revolving credit facility.

Alan Hirzel, CEO of Abcam, said: "This acquisition represents a compelling opportunity to secure a proven portfolio of high-quality products, including a leading portfolio of biochemical and cell-based assay kits, that will allow us to better serve customer needs.

“BioVision has sustained strong growth over many years and, together with Abcam’s brand, reach and capabilities, we are confident we are well positioned to build on this success and reinforce Abcam’s ability to serve life scientists globally."

Analysts at Peel Hunt described the acquisition as a “compeling strategic fit.”

They said: “We think this deal is an incremental positive to the Abcam story, helping to accelerate its in-house innovation and product manufacture/catalogue: as evidenced by the improved margin trajectory as well as securing that other primary marker of Abcam’s success: revenue growth.

“Our positivity is muted a little by the price for BioVision (at 10x revenue), but we recognise that high growth tools companies that add value to Abcam’s offering are very hard to find.”

Abcam shares rose 1.91%, or 26p, to 1,384.00p.
Newsletter

Related Articles

Beautiful Virgin Islands
0:00
0:00
Close
Texas Enacts Law Allowing Gold and Silver Transactions
China Unveils Miniature Insect-Like Surveillance Drone
OpenAI Secures Multimillion-Dollar AI Contracts with Pentagon, India, and Grab
Marc Marquez Claims Victory at Dutch Grand Prix Amidst Family Misfortune
Germany Votes to Suspend Family Reunification for Asylum Seekers
Elon Musk Critiques Senate Budget Proposal Over Job Losses and Strategic Risks
Los Angeles Riots ended with Federal Investigations into Funding
Budapest Pride Parade Draws 200,000 Participants Amid Government Ban
Southern Europe Experiences Extreme Heat
Xiaomi's YU7 SUV Launch Garners Record Pre-Orders Amid Market Challenges
Jeff Bezos and Lauren Sanchez's Lavish Wedding in Venice
Russia Launches Largest Air Assault on Ukraine Since Invasion
Education Secretary Announces Overhaul of Complaints System Amid Rising Parental Grievances
Massive Anti-Government Protests Erupt in Belgrade
Trump Ends Trade Talks with Canada Over Digital Services Tax
UK Government Softens Welfare Reform Plans Amid Labour Party Rebellion
Labour Faces Rebellion Over Disability Benefit Reforms Ahead of Key Vote
Jeff Bezos and Lauren Sánchez Host Lavish Wedding in Venice Amid Protests
Trump Asserts Readiness for Further Strikes on Iran Amid Nuclear Tensions
North Korea to Open New Beach Resort to Boost Tourism Economy
UK Labour Party Faces Internal Tensions Over Welfare Reforms
Andrew Cuomo Hints at Potential November Comeback Amid Democratic Primary Results
Curtis Sliwa Champions His Vision for New York City Amid Rising Crime Concerns
Federal Reserve Proposes Changes to Capital Rule Affecting Major Banks
EU TO HUNGARY: LET THEM PRIDE OR PREP FOR SHADE. ORBÁN TO EU: STAY IN YOUR LANE AND FIX YOUR OWN MESS.
Trump Escalates Criticism of Media Over Iran Strike Coverage
Trump Announces Upcoming US-Iran Meeting Amid Controversial Airstrikes
Trump Moves to Reshape Middle East Following Israel-Iran Conflict
Big Four Accounting Firms Fined in Exam Cheating Scandal
NATO Members Agree to 5% Defense Spending Target by 2035
Australia's Star Casino Secures $195 Million Rescue Package Amid Challenges
UK to Enhance Nuclear Capabilities with Acquisition of F-35A Fighter Jets
Russian Shadow Payments via Cryptocurrency Reach $9 Billion
Explosions Rock Doha as Iranian Missiles Target Qatar
“You Have 12 Hours to Flee”: Israeli Threat Campaign Targets Surviving Iranian Officials
Macron and Merz: Europe must arm itself in an unstable world
Germany and Italy Under Pressure to Repatriate $245bn of Gold from US Vaults
Airlines Evaluate Flight Cancellations Amid Escalating US-Iran Tensions
Starmer Invites Innovators to Join Government Talent Scheme
UK Economy’s Strong Opening Quarter Shows Signs of Cooling
Harrods Seeks Court Order to Secure Al Fayed Estate for Victims
BA and Singapore Airlines Cancel Dubai Flights Amid Middle East Tensions
Trump Faces Backlash from MAGA Base Over Iran Strikes
Meta Bets $14 B on Alexandr Wang to Drive AI Ambitions
WATCH: Israeli forces show the aftermath of a massive airstrike at Iran's Isfahan nuclear site
FedEx Founder Fred Smith, ‘Heart and Soul’ of the Company, Dies at 80
Chinese Factories Shift Away from U.S. Amid Trump‑Era Tariffs
Pimco Seizes Opportunity in Japan’s Dislocated Bond Market
Labubu Doll Drives Pop Mart to Status as China’s Most Valuable Toy Maker
Global Coal Demand Defies Paris Accord Goals
×